Current perspectives on the modulation of thermo-TRP channels: New advances and therapeutic implications

Expert Review of Clinical Pharmacology

Volumn 3, Issue 5, 2010, Pages 687-704

  Vay, Laura ^a   Gu, Chunjing ^a   McNaughton, Peter A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

artemin; hyperalgesia; neurotrophic factor; nociceptor; pain; sensitization; thermo transient receptor potential ion channel; TRPV1

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRADYKININ; CAPSAICIN; CARVACROL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INSULIN; ION CHANNEL; NERVE GROWTH FACTOR RECEPTOR; NEUROGESX; NEUROTROPHIN; POTASSIUM CHANNEL; PROSTAGLANDIN; PROTON; RESINIFERATOXIN; RN 1734; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 2; VANILLOID RECEPTOR 3; VANILLOID RECEPTOR 4;

ANDROGRAPHIS PANICULATA; CELL PERMEABILIZATION; CELL PH; DRUG TARGETING; HEAT SENSATION; HUMAN; HYPERALGESIA; HYPERTHERMIA; INFLAMMATION; NOCICEPTIVE RECEPTOR; NONHUMAN; OREGANO; PAIN; REVIEW; SENSORY NERVE CELL;

EID: 77956818704     PISSN: 17512433     EISSN: None     Source Type: Journal    
DOI: 10.1586/ecp.10.41     Document Type: Review

References (204)

1. Sherrington CS. The Integrative Action of the Nervous System. Scribner, NY, USA (1906).
2. Wood JN, Perl ER. Pain. Curr. Opin. Genet. Dev. 9, 328-332 (1999).
3. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 288, 1765-1769 (2000).
4. Montell C. The TRP superfamily of cation channels. Sci. STKE re3 (2005).
5. Talavera K, Yasumatsu K, Voets T et al. Heat activation of TRPM5 underlies thermal sensitivity of sweet taste. Nature 438, 1022-1025 (2005).
6. Cesare P, McNaughton PA. A novel heat-activated current in nociceptive neurons, and its sensitization by bradykinin. Proc. Natl Acad. Sci. USA 93, 15435-15439 (1996).
7. Caterina MJ, Schumacher MA, Tominaga M et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389, 816-824 (1997).
8. Oh U, Sun WH, Kim D. Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons. J. Neurosci. 16, 1659-1667 (1996).
9. Jung J, Sun WH, Kwak J et al. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J. Neuroscience 19, 529-538 (1999).
10. Tominaga M, Caterina MJ, Malmberg AB et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21, 531-543 (1998).
11. Zhu MX. Understanding the role of voltage gating of polymodal TRP channels. J. Physiol. 585, 321-322 (2007).
12. Voets T, Droogmans G, Wissenbach U et al. The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature 430, 748-754 (2004).
13. Bonnington JK, McNaughton PA. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J. Physiol. 551, 433-446 (2003).
14. Tominaga M, Wada M, Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc. Natl Acad. Sci. USA 98, 6951-6956 (2001).
15. Vellani V, Mapplebeck S, Moriondo A, Davis JB, McNaughton PA. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J. Physiol. 534, 813-825 (2001).
16. Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 24, 487-517 (2001).
17. Ryu S, Liu B, Qin F. Low pH potentiates both capsaicin binding and channel gating of VR1 receptors. J. Gen. Physiol. 122, 45-61 (2003).
18. Trevisani M, Smart D, Gunthorpe MJ et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat. Neurosci. 5(6), 546-551 (2002).
19. Ross RA. Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140, 790-801 (2003).
20. Hwang SW, Cho H, Kwak J et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl Acad. Sci. USA 97, 6155-6160 (2000).
21. Caterina MJ, Leffler A, Malmberg AB et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288, 306-313 (2000).
22. Davis JB, Gray J, Gunthorpe MJ et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405, 183-187 (2000).
23. Moriyama T, Higashi T, Togashi K et al. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain 1, 3 (2005).
24. Caterina MJ. Vanilloid receptors take a TRP beyond the sensory afferent. Pain 105, 5-9 (2003).
25. Caterina MJ, Julius D. Sense and specificity: a molecular identity for nociceptors. Curr. Opin. Neurobiol. 9, 525-530 (1999).
26. Bender FL, Mederos YS, Li Y et al. The temperature-sensitive ion channel TRPV2 is endogenously expressed and functional in the primary sensory cell line F-11. Cell Physiol. Biochem. 15, 183-194 (2005).
27. Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 398, 436-441 (1999).
28. Muraki K, Iwata Y, Katanosaka Y et al. TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ. Res. 93, 829-838 (2003).
29. Hu HZ, Gu Q, Wang C et al. 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J. Biol. Chem. 279, 35741-35748 (2004).
30. Qin N, Neeper MP, Liu Y et al. TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J. Neurosci. 28, 6231-6238 (2008).
31. Shimosato G, Amaya F, Ueda M et al. Peripheral inflammation induces up-regulation of TRPV2 expression in rat DRG. Pain 119, 225-232 (2005).
32. Frederick J, Buck ME, Matson DJ, Cortright DN. Increased TRPA1, TRPM8, and TRPV2 expression in dorsal root ganglia by nerve injury. Biochem. Biophys. Res. Commun. 358, 1058-1064 (2007).
33. Park U, Vastani N, Guan Y, Srinivasa NR, Koltzenburg M, Caterina MJ. Evaluation of TRPV2 function in mouse thermal nociception. Presented at: 12th World Congress on Pain. Glasgow, Scotland, 17-22 August 2008.
34. Peier AM, Reeve AJ, Andersson DA et al. A heat-sensitive TRP channel expressed in keratinocytes. Science 296, 2046-2049 (2002).
35. Smith GD, Gunthorpe MJ, Kelsell RE et al. TRPV3 is a temperature- sensitive vanilloid receptor-like protein. Nature 418, 186-190 (2002).
36. Xu H, Ramsey IS, Kotecha SA et al. TRPV3 is a calcium-permeable temperature-sensitive cation channel. Nature 418, 181-186 (2002).
37. Watanabe H, Vriens J, Suh SH et al. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J. Biol. Chem. 277, 47044-47051 (2002).
38. Lee H, Caterina MJ. TRPV channels as thermosensory receptors in epithelial cells. Pflugers Arch. 451(1),160-167 (2005).
39. Moqrich A, Hwang SW, Earley TJ et al. Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science 307, 1468-1472 (2005).
40. Todaka H, Taniguchi J, Satoh J, Mizuno A, Suzuki M. Warm temperature-sensitive transient receptor potential vanilloid 4 (TRPV4) plays an essential role in thermal hyperalgesia. J. Biol. Chem. 279, 35133-35138 (2004).
41. Xu H, Delling M, Jun JC, Clapham DE. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat. Neurosci. 9, 628-635 (2006).
42. Zimmermann K, Leffler A, Fischer MM et al. The TRPV1/2/3 activator 2-aminoethoxydiphenyl borate sensitizes native nociceptive neurons to heat in wildtype but not TRPV1 deficient mice. Neuroscience 135, 1277-1284 (2005).
43. Watanabe H, Davis JB, Smart D et al. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. J. Biol. Chem. 277, 13569-13577 (2002).
44. Fan HC, Zhang X, McNaughton PA. Activation of the TRPV4 ion channel is enhanced by phosphorylation. J. Biol. Chem. 284, 27884-27891 (2009).
45. Smith PL, Maloney KN, Pothen RG, Clardy J, Clapham DE. Bisandrographolide from Andrographis paniculata activates TRPV4 channels. J. Biol. Chem. 281, 29897-29904 (2006).
46. Mandadi S, Sokabe T, Shibasaki K et al. TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP. Pflugers Arch. 458, 1093-1102 (2009).
47. Gevaert T, Vriens J, Segal A et al. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J. Clin. Invest. 117, 3453-3462 (2007)
48. Huang SM, Lee H, Chung MK et al. Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2. J. Neurosci. 28, 13727-13737 (2008).
49. Alessandri-Haber N, Joseph E, Dina OA, Liedtke W, Levine JD. TRPV4 mediates pain-related behavior induced by mild hypertonic stimuli in the presence of inflammatory mediator. Pain 118, 70-79 (2005).
50. Nilius B, Voets T. TRP channels: a TR(I)P through a world of multifunctional cation channels. Pflugers Arch. 451, 1-10 (2005).
51. Peier AM, Moqrich A, Hergarden AC et al. A TRP channel that senses cold stimuli and menthol. Cell 108, 705-715 (2002).
52. McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416, 52-58 (2002).
53. De la Pena E, Malkia A, Cabedo H, Belmonte C, Viana F. The contribution of TRPM8 channels to cold sensing in mammalian neurones. J. Physiol. 567, 415-426 (2005).
54. Chuang HH, Neuhausser WM, Julius D. The super-cooling agent icilin reveals a mechanism of coincidence detection by a temperature-sensitive TRP channel. Neuron 43, 859-869 (2004).
55. Reid G, Babes A, Pluteanu F. A cold- and menthol-activated current in rat dorsal root ganglion neurones: properties and role in cold transduction. J. Physiol. 545, 595-614 (2002). (Pubitemid 36004391)
56. Okazawa M, Inoue W, Hori A et al. Noxious heat receptors present in cold-sensory cells in rats. Neurosci. Lett. 359, 33-36 (2004).
57. Babes A, Zorzon D, Reid G. Two populations of cold-sensitive neurons in rat dorsal root ganglia and their modulation by nerve growth factor. Eur. J. Neurosci. 20, 2276-2282 (2004).
58. Dhaka A, Murray AN, Mathur J et al. TRPM8 is required for cold sensation in mice. Neuron 54, 371-378 (2007).
59. Colburn RW, Lubin ML, Stone DJ Jr et al. Attenuated cold sensitivity in TRPM8 null mice. Neuron 54, 379-386 (2007).
60. Bautista DM, Siemens J, Glazer JM et al. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 448, 204-208 (2007).
61. Story GM, Peier AM, Reeve AJ et al. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112, 819-829 (2003).
62. Kwan KY, Allchorne AJ, Vollrath MA et al. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 50, 277-289 (2006).
63. Bautista DM, Jordt SE, Nikai T et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124, 1269-1282 (2006).
64. Karashima Y, Talavera K, Everaerts W et al. TRPA1 acts as a cold sensor in vitro and in vivo. Proc. Natl Acad. Sci. USA 106, 1273-1278 (2009).
65. Fajardo O, Meseguer V, Belmonte C, Viana F. TRPA1 channels mediate cold temperature sensing in mammalian vagal sensory neurons: pharmacological and genetic evidence. J. Neurosci. 28, 7863-7875 (2008).
66. Belmonte C, Brock JA, Viana F. Converting cold into pain. Exp. Brain Res. 196, 13-30 (2009).
67. Zurborg S, Yurgionas B, Jira JA, Caspani O, Heppenstall PA. Direct activation of the ion channel TRPA1 by Ca2+. Nat. Neurosci. 10, 277-279 (2007).
68. Doerner JF, Gisselmann G, Hatt H, Wetzel CH. Transient receptor potential channel A1 is directly gated by calcium ions. J. Biol. Chem. 282, 13180-13189 (2007).
69. Reid G. ThermoTRP channels and cold sensing: what are they really up to? Pflugers Arch. 451, 250-263 (2005).
70. McNamara CR, Mandel-Brehm J, Bautista DM et al. TRPA1 mediates formalin-induced pain. Proc. Natl Acad. Sci. USA 104, 13525-13530 (2007).
71. Obata K, Katsura H, Mizushima T et al. TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J. Clin. Invest. 115, 2393-2401 (2005).
72. Katsura H, Obata K, Mizushima T et al. Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J. Neurosci. 26, 8680-8690 (2006).
73. Katsura H, Tsuzuki K, Noguchi K, Sakagami M. Differential expression of capsaicin-, menthol-, and mustard oil-sensitive receptors in naive rat geniculate ganglion neurons. Chem. Senses 31, 681-688 (2006).
74. Katsura H, Obata K, Mizushima T et al. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp. Neurol. 200, 112-123 (2006).
75. Gracheva EO, Ingolia NT, Kelly YM et al. Molecular basis of infrared detection by snakes. Nature 464, 1006-1011 (2010).
76. Bautista DM, Movahed P, Hinman A et al. Pungent products from garlic activate the sensory ion channel TRPA1. Proc. Natl Acad. Sci. USA 102, 12248-12252 (2005).
77. Bandell M, Story GM, Hwang SW et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41, 849-857 (2004).
78. Hinman A, Chuang HH, Bautista DM, Julius D. TRP channel activation by reversible covalent modification. Proc. Natl Acad. Sci. USA 103, 19564-19568 (2006).
79. Macpherson LJ, Dubin AE, Evans MJ et al. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 445, 541-545 (2007).
80. Hu H, Tian J, Zhu Y et al. Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs. Pflugers Arch. 459, 579-592 (2010).
81. Karashima Y, Damann N, Prenen J et al. Bimodal action of menthol on the transient receptor potential channel TRPA1. J. Neurosci. 27, 9874-9884 (2007).
82. Dhaka A, Viswanath V, Patapoutian A. TRP ion channels and temperature sensation. Annu. Rev. Neurosci. 29, 135-161 (2006).
83. Corey DP, Garcia-Anoveros J, Holt JR et al. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature 432, 723-730 (2004).
84. Huang J, Zhang X, McNaughton PA. Modulation of temperature-sensitive TRP channels. Semin. Cell Dev. Biol. 17, 638-645 (2006).
85. Bhave G, Hu HJ, Glauner KS et al. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc. Natl Acad. Sci. USA 100, 12480-12485 (2003).
86. Mandadi S, Tominaga T, Numazaki M et al. Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCe-mediated phosphorylation at S800. Pain 123, 106-116 (2006).
87. Numazaki M, Tominaga T, Toyooka H, Tominaga M. Direct phosphorylation of capsaicin receptor VR1 by protein kinase Ce and identification of two target serine residues. J. Biol. Chem. 277, 13375-13378 (2002).
88. Studer M, McNaughton PA. Modulation of single-channel properties of TRPV1 by phosphorylation. J. Physiol. (2010) (In press).
89. Rathee PK, Distler C, Obreja O et al. PKA/AKAP/VR-1 module: a common link of Gs-mediated signaling to thermal hyperalgesia. J. Neurosci. 22, 4740-4745 (2002).
90. Lopshire JC, Nicol GD. The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicin-elicited current in rat sensory neurons: whole-cell and single-channel studies. J. Neurosci. 18, 6081-6092 (1998).
91. Bhave G, Zhu W, Wang H et al. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 35, 721-731 (2002).
92. Zhang X, Li L, McNaughton PA. Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150. Neuron 59, 450-461 (2008).
93. Jeske NA, Patwardhan AM, Ruparel NB et al. A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1. Pain 146, 301-307 (2009).
94. Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 408, 985-990 (2000).
95. Xu F, Satoh E, Iijima T. Protein kinase C-mediated Ca2+ entry in HEK 293 cells transiently expressing human TRPV4. Br. J. Pharmacol. 140, 413-421 (2003).
96. Xu H, Zhao H, Tian W et al. Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J. Biol. Chem. 278, 11520-11527 (2003).
97. Wegierski T, Lewandrowski U, Muller B, Sickmann A, Walz G. Tyrosine phosphorylation modulates the activity of TRPV4 in response to defined stimuli. J. Biol. Chem. 284, 2923-2933 (2009).
98. Stokes AJ, Shimoda LM, Koblan- Huberson M, Adra CN, Turner H. A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J. Exp. Med. 200, 137-147 (2004).
99. Penna A, Juvin V, Chemin J et al. PI3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane. Cell Calcium 39, 495-507 (2006).
100. Xu H, Delling M, Jun JC, Clapham DE. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat. Neurosci. 9, 628-635 (2006).
101. Premkumar LS, Raisinghani M, Pingle SC, Long C, Pimentel F. Downregulation of transient receptor potential melastatin 8 by protein kinase C-mediated dephosphorylation. J. Neurosci. 25, 11322-11329 (2005).
102. Linte RM, Ciobanu C, Reid G, Babes A. Desensitization of cold- and menthol-sensitive rat dorsal root ganglion neurones by inflammatory mediators. Exp. Brain Res. 178(1), 89-98 (2006).
103. Bavencoffe A, Gkika D, Kondratskyi A et al. The transient receptor potential channel TRPM8 is inhibited via the a 2A adrenoreceptor signaling pathway. J. Biol. Chem. 285, 9410-9419 (2010).
104. Wang YY, Chang RB, Waters HN, McKemy DD, Liman ER. The nociceptor ion channel TRPA1 is potentiated and inactivated by permeating calcium ions. J. Biol. Chem. 283, 32691-32703 (2008).
105. Schmidt M, Dubin AE, Petrus MJ, Earley TJ, Patapoutian A. Nociceptive signals induce trafficking of TRPA1 to the plasma membrane. Neuron 64, 498-509 (2009).
106. Dai Y, Wang S, Tominaga M et al. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J. Clin. Invest. 117, 1979-1987 (2007).
107. Kim D, Cavanaugh EJ, Simkin D. Inhibition of transient receptor potential A1 channel by phosphatidylinositol-4,5- bisphosphate. Am. J. Physiol. Cell Physiol. 295, C92-C99 (2008).
108. Karashima Y, Prenen J, Meseguer V et al. Modulation of the transient receptor potential channel TRPA1 by phosphatidylinositol 4,5-biphosphate manipulators. Pflugers Arch. 457, 77-89 (2008).
109. Farinas I. Neurotrophin actions during the development of the peripheral nervous system. Microsc. Res. Tech. 45, 233-242 (1999).
110. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu. Rev. Neurosci. 289-317 (1996).
111. Weskamp G, Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J. Neurochem. 48, 1779-1786 (1987).
112. Lewin GR, Ritter AM, Mendell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 13, 2136-2148 (1993).
113. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci. 6, 1903-1912 (1994).
114. Pezet S, Krzyzanowska A, Wong LF et al. Reversal of neurochemical changes and pain-related behavior in a model of neuropathic pain using modified lentiviral vectors expressing GDNF. Mol. Ther. 13, 1101-1109 (2006).
115. McMahon SB, Armanini MP, Ling LH, Phillips HS. Expression and coexpression of TRK receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 12, 1161-1171 (1994).
116. Kobayashi K, Fukuoka T, Obata K et al. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J. Comp. Neurol. 493, 596-606 (2005).
117. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36, 57-68 (2002).
118. Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J. 24, 4211-4223 (2005).
119. Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J. Gen. Physiol. 128, 509-522 (2006).
120. Zhu W, Oxford GS. Phosphoinositide-3- kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1. Mol. Cell. Neurosci. 34, 689-700 (2007).
121. Van Buren JJ, Bhat S, Rotello R, Pauza ME, Premkumar LS. Sensitization and translocation of TRPV1 by insulin and IGF-I. Mol. Pain 1, 17 (2005).
122. Kanzaki M, Zhang YQ, Mashima H et al. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I. Nat. Cell Biol. 1, 165-170 (1999).
123. Boels K, Glassmeier G, Herrmann D et al. The neuropeptide head activator induces activation and translocation of the growth-factor-regulated Ca(2+)-permeable channel GRC. J. Cell Sci. 114, 3599-3606 (2001).
124. Hisanaga E, Nagasawa M, Ueki K et al. Regulation of calcium-permeable TRPV2 channel by insulin in pancreatic b-cells. Diabetes 58, 174-184 (2009).
125. Airaksinen MS, Titievsky A, SaarMiller M.A. GDNF family neurotrophic factor signaling: four masters, one servant? Mol. Cell. Neurosci. 13, 313-325 (1999).
126. Albers KM, Woodbury CJ, Ritter AM, Davis BM, Koerber HR. Glial cell-line-derived neurotrophic factor expression in skin alters the mechanical sensitivity of cutaneous nociceptors. J. Neurosci. 26, 2981-2990 (2006).
127. Malin SA, Molliver DC, Koerber HR et al. Glial cell line-derived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. J. Neurosci. 26, 8588-8599 (2006).
128. Gunthorpe MJ, Chizh BA. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov. Today 14, 56-67 (2009).
129. Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat. Rev. Drug Discov. 6, 357-372 (2007).
130. Wong GY, Gavva NR. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks. Brain Res. Rev. 60, 267-277 (2009).
131. Kym PR, Kort ME, Hutchins CW. Analgesic potential of TRPV1 antagonists. Biochem. Pharmacol. 78, 211-216 (2009).
132. Gomtsyan A, Faltynek CR. Vanilloid Receptor TRPV1 in Drug Discovery. Hoboken NJ (Ed.). John Wiley & Sons, NJ, USA (2010).
133. Cui M, Honore P, Zhong C et al. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J. Neurosci. 26, 9385-9393 (2006).
134. Gibson HE, Edwards JG, Page RS, Van Hook MJ, Kauer JA. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 57, 746-759 (2008).
135. Marsch R, Foeller E, Rammes G et al. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J. Neurosci. 27, 832-839 (2007).
136. Huang SM, Lee H, Chung MK et al. Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2. J. Neurosci. 28, 13727-13737 (2008).
137. Gavva NR, Treanor JJ, Garami A et al. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 136, 202-210 (2008).
138. Gavva NR, Bannon AW, Surapaneni S et al. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J. Neurosci. 27, 3366-3374 (2007).
139. Steiner AA, Turek VF, Almeida MC et al. Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J. Neurosci. 27, 7459-7468 (2007).
140. Lehto SG, Tamir R, Deng H et al. Antihyperalgesic effects of (R,E)-N-(2- hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2- (piperidin-1-yl)-4-(tri fluoromethyl) phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats. J. Pharmacol. Exp. Ther. 326, 218-229 (2008).
141. Backonja MM. Defining neuropathic pain. Anesth. Analg. 97, 785-790 (2003).
142. Culshaw AJ, Bevan S, Christiansen M et al. Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain. J. Med. Chem. 49, 471-474 (2006).
143. Ghilardi JR, Rohrich H, Lindsay TH et al. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J. Neurosci. 25, 3126-3131 (2005).
144. Honore P, Wismer CT, Mikusa J et al. A-425619 [1-isoquinolin-5-yl-3-(4- trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J. Pharmacol. Exp. Ther. 314, 410-421 (2005).
145. Jakab B, Helyes Z, Varga A et al. Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat. Eur. J. Pharmacol. 517, 35-44 (2005). (Pubitemid 40910250)
146. Pomonis JD, Harrison JE, Mark L et al. N-(4-tertiarybutylphenyl)-4-(3- cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 306, 387-393 (2003).
147. Walker KM, Urban L, Medhurst SJ et al. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 304, 56-62 (2003).
148. Bianchi BR, El Kouhen R, Neelands TR et al. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor. J. Pharmacol. Exp. Ther. 323, 285-293 (2007).
149. Bianchi BR, El Kouhen R, Chen J, Puttfarcken PS. Binding of [(3)H] A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord. Eur. J. Pharmacol. 633, 15-23 (2010).
150. Gomtsyan A, Bayburt EK, Schmidt RG et al. Identification of (R)-1-(5-tert-butyl- 2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management. J. Med. Chem. 51, 392-395 (2008).
151. Doherty EM, Fotsch C, Bannon AW et al. Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate. J Med. Chem. 50, 3515-3527 (2007).
152. Crutchlow M. Pharmacologic inhibition of TRPV1 impairs sensation of potentially injurious heat in healthy subjects. Presented at: ASCPT 2009 Annual Meeting. MD, USA, 18-21 March 2009.
153. Honore P, Chandran P, Hernandez G et al. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain 142, 27-35 (2009).
154. Wang HL, Katon J, Balan C et al. Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties. J. Med. Chem. 50, 3528-3539 (2007).
155. Klionsky L, Tamir R, Gao B et al. Species-specific pharmacology of trichloro(sulfanyl) ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists. Mol. Pain 3, 39 (2007).
156. Tamayo N, Liao H, Stec MM et al. Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists. J. Med. Chem. 51, 2744-2757 (2008).
157. Gunthorpe MJ, Hannan SL, Smart D et al. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor. J. Pharmacol. Exp. Ther. 321, 1183-1192 (2007).
158. Rami HK, Thompson M, Wyman P et al. Discovery of small molecule antagonists of TRPV1. Bioorg. Med. Chem. Lett. 14, 3631-3634 (2004).
159. Rami HK, Thompson M, Stemp G et al. Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development. Bioorg. Med. Chem. Lett. 16, 3287-3291 (2006).
160. Chizh BA, ODonnell MB, Napolitano A et al. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 132, 132-141 (2007).
161. Charrua A, Cruz CD, Narayanan S et al. GRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models. J. Urol. 181, 379-386 (2009).
162. Jeske NA, Diogenes A, Ruparel NB et al. A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1. Pain 138, 604-616 (2008).
163. Schnizler K, Shutov LP, Van Kanegan MJ et al. Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons. J. Neurosci. 28, 4904-4917 (2008).
164. Novakova-Tousova K, Vyklicky L, Susankova K et al. Functional changes in the vanilloid receptor subtype 1 channel during and after acute desensitization. Neuroscience 149, 144-154 (2007).
165. Backonja MM, Walk D, Edwards RR et al. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin. J. Pain 25, 641-647 (2009).
166. Simpson DM, Brown S, Tobias J. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 70, 2305-2313 (2008).
167. Chung MK, Guler AD, Caterina MJ. TRPV1 shows dynamic ionic selectivity during agonist stimulation. Nat. Neurosci. 11, 555-564 (2008).
168. Binshtok AM, Bean BP, Woolf CJ. Inhibition of nociceptors by TRPV1- mediated entry of impermeant sodium channel blockers. Nature 449, 607-610 (2007).
169. Juvin V, Penna A, Chemin J, Lin YL, Rassendren FA. Pharmacological characterization and molecular determinants of the activation of transient receptor potential V2 channel orthologs by 2-aminoethoxydiphenyl borate. Mol. Pharmacol. 72, 1258-1268 (2007).
170. Neeper MP, Liu Y, Hutchinson TL et al. Activation properties of heterologously expressed mammalian TRPV2: evidence for species dependence. J. Biol. Chem. 282, 15894-15902 (2007).
171. Nagasawa M, Nakagawa Y, Tanaka S, Kojima I. Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages. J. Cell Physiol. 210, 692-702 (2007).
172. Leffler A, Linte RM, Nau C, Reeh P, Babes A. A high-threshold heat-activated channel in cultured rat dorsal root ganglion neurons resembles TRPV2 and is blocked by gadolinium. Eur. J. Neurosci. 26, 12-22 (2007).
173. Stotz SC, Vriens J, Martyn D, Clardy J, Clapham DE. Citral sensing by transient [corrected] receptor potential channels in dorsal root ganglion neurons. PLoS ONE 3, e2082 (2008).
174. Gullapalli S, Thomas A, Lingam PR, Kattige V, Gudi GS, Khairatkar-Joshi N. GRC 15133, a novel, selective TRPV3 antagonist with anti-hyperalgesic effects in inflammatory and neuropathic pain. Presented at: CHI-World Pharmaceutical Congress PA, USA, 12-14 May 2008.
175. Moran MM, Wei DS, Zhen X et al. Potent and selective antagonists validate TRPV3 as a target for analgesic therapeutics. Abstr. Soc. Neurosci. 143.5/J6 (2007).
176. Alessandri-Haber N, Dina OA, Joseph EK, Reichling D, Levine JD. A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators. J. Neurosci. 26, 3864-3874 (2006).
177. Grant AD, Cottrell GS, Amadesi S et al. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J. Physiol. 578, 715-733 (2007).
178. Chen X, Alessandri-Haber N, Levine JD. Marked attenuation of inflammatory mediator-induced C-fiber sensitization for mechanical and hypotonic stimuli in TRPV4-/- mice. Mol. Pain 3, 31 (2007).
179. Vergnolle N, Cenac N, Altier C et al. A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation. Br. J. Pharmacol. 159, 1161-1173 (2010).
180. Alessandri-Haber N, Dina OA, Yeh JJ et al. Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat. J. Neurosci. 24, 4444-4452 (2004).
181. Levine JD, Alessandri-Haber N. TRP channels: targets for the relief of pain. Biochim. Biophys. Acta 1772, 989-1003 (2007).
182. Vincent F, Acevedo A, Nguyen MT et al. Identification and characterization of novel TRPV4 modulators. Biochem. Biophys. Res. Commun. 389, 490-494 (2009).
183. Broad LM, Mogg AJ, Beattie RE et al. TRP channels as emerging targets for pain therapeutics. Expert. Opin. Ther. Targets. 13, 69-81 (2009).
184. Diogenes A, Akopian AN, Hargreaves KM. NGF up-regulates TRPA1: implications for orofacial pain. J. Dent. Res. 86, 550-555 (2007).
185. Caceres AI, Brackmann M, Elia MD et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc. Natl Acad. Sci. USA 106, 9099-9104 (2009).
186. Petrus M, Peier AM, Bandell M et al. A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition. Mol. Pain 3, 40 (2007).
187. DeFalco J, Steiger D, Gustafson A et al. Oxime derivatives related to AP18: agonists and antagonists of the TRPA1 receptor. Bioorg. Med. Chem. Lett. 20(1), 276-279 (2010).
188. Eid SR, Crown ED, Moore EL et al. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol. Pain 4, 48 (2008).
189. Wei H, Hamalainen MM, Saarnilehto M, Koivisto A, Pertovaara A. Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals. Anesthesiology 111, 147-154 (2009).
190. Fleetwood-Walker SM, Proudfoot CW, Garry EM et al. Cold comfort pharm. Trends Pharmacol. Sci. 28, 621-628 (2007).
191. Proudfoot CJ, Garry EM, Cottrell DF et al. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr. Biol. 16, 1591-1605 (2006).
192. Xing H, Chen M, Ling J, Tan W, Gu JG. TRPM8 mechanism of cold allodynia after chronic nerve injury. J. Neurosci. 27, 13680-13690 (2007).
193. Behrendt HJ, Germann T, Gillen C, Hatt H, Jostock R. Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. Br. J. Pharmacol. 141, 737-745 (2004).
194. Takashima Y, Daniels RL, Knowlton W et al. Diversity in the neural circuitry of cold sensing revealed by genetic axonal labeling of transient receptor potential melastatin 8 neurons. J. Neurosci. 27, 14147-14157 (2007).
195. Viana F, De la Pena E, Belmonte C. Specificity of cold thermotransduction is determined by differential ionic channel expression. Nat. Neurosci. 5, 254-260 (2002).
196. Xing H, Ling J, Chen M, Gu JG. Chemical and cold sensitivity of two distinct populations of TRPM8-expressing somatosensory neurons. J. Neurophysiol. 95, 1221-1230 (2006).
197. Malkia A, Madrid R, Meseguer V et al. Bidirectional shifts of TRPM8 channel gating by temperature and chemical agents modulate the cold sensitivity of mammalian thermoreceptors. J. Physiol. 581, 155-174 (2007).
198. Malkia A, Pertusa M, Fernandez-Ballester G, Ferrer-Montiel A, Viana F. Differential role of the menthol-binding residue Y745 in the antagonism of thermally gated TRPM8 channels. Mol. Pain 5, 62 (2009).
199. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol. Rev. 87, 165-217 (2007).
200. Chizh BA, ODonnell MB, Napolitano A et al. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 132, 132-141 (2007).
201. Colsoul B, Nilius B, Vennekens R. On the putative role of transient receptor potential cation channels in asthma. Clin. Exp. Allergy 39, 1456-1466 (2009).
202. Viana F, Ferrer-Montiel A. TRPA1 modulators in preclinical development. Expert Opin. Ther. Pat. 19, 1787-1799 (2009).
203. Neurogesx www.neurogesx.com/trpv1-hcp
204. Anesiva www.anesiva.com/wt/page/cl-dataadlea